Deborah Levenson. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antirheumatic Agents/administration & dosageAntirheumatic Agents/chemical synthesisAntirheumatic Agents/therapeutic useChildHumansImmune System Diseases/drug therapyImmune System Diseases/geneticsImmune System Diseases/immunologyImmune System Diseases/physiopathologyInfantInflammation/drug therapyInflammation/geneticsInterleukin 1 Receptor Antagonist Protein/administration & dosageInterleukin 1 Receptor Antagonist Protein/chemical synthesisInterleukin 1 Receptor Antagonist Protein/deficiencyInterleukin 1 Receptor Antagonist Protein/geneticsInterleukin 1 Receptor Antagonist Protein/therapeutic useMaleMutationNetherlandsNewfoundland and LabradorPuerto RicoSyndrome
Substances: See more » Antirheumatic AgentsIL1RN protein, humanInterleukin 1 Receptor Antagonist Protein
Year: 2009 PMID: 19697428 DOI: 10.1002/ajmg.a.33102
Source DB: PubMed Journal: Am J Med Genet A ISSN: 1552-4825 Impact factor: 2.802